Urinary Bladder Neoplasm

Oncology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Nektar Therapeutics
Nektar TherapeuticsSAN FRANCISCO, CA
1 program
1
BempegaldesleukinPhase 2
M&
Merck & Co.RAHWAY, NJ
1 program
Evaluation of muscle mass and muscle functionN/A1 trial
Active Trials
NCT04144270Unknown30Est. Apr 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Merck & Co.Evaluation of muscle mass and muscle function

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT04144270Merck & Co.Evaluation of muscle mass and muscle function

The Importance of Muscle Function in Patients With Disseminated Bladder Cancer

Start: Nov 2019Est. completion: Apr 202130 patients
N/AUnknown

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
21m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
21m ago

Office Administrator

SystImmune
21m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
32m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
35m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
35m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)